Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... [Yahoo! Finance]
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Yahoo! Finance
Medical Costs Impact: $24 million increase due to higher claims from prior periods and $18 million increase due to acceleration in medical costs in Q3. Revenue Guidance: Updated to $2.55 billion to $2.575 billion for 2024. Adjusted EBITDA Guidance: Revised to $161 million to $175 million for 2024, with Q4 guidance of $22 million to $37 million. Cash from Operations: $18.7 million in Q3 2024; $67.2 million year-to-date. New Revenue Agreements: Six new agreements in Q3 2024, the largest number in a single quarter since the company's founding. Financing: Obtained $250 million in incremental committed financing, including a new $125 million term loan and a $75 million delayed draw term loan. Warning! GuruFocus has detected 3 Warning Signs with EVH. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Evolent Health Inc ( NYSE:EVH ) announced six new revenue agreements in the third quarter, ma
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent announces Dr. Von Nguyen as incoming Chief Medical Officer, effective January 1PR Newswire
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at BTIG Research from $36.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $45.00 to $15.00. They now have an "overweight" rating on the stock.MarketBeat
- Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode [Yahoo! Finance]Yahoo! Finance
- Evolent Health, Inc. (NYSE: EVH) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $34.00 to $28.00. They now have an "outperform" rating on the stock.MarketBeat
EVH
Earnings
- 11/7/24 - Miss
EVH
Sec Filings
- 12/11/24 - Form 8-K
- 11/12/24 - Form SC
- 11/8/24 - Form 10-Q
- EVH's page on the SEC website